Podcasts about contract research organization

This episode of The Stem Cell Report will discuss the process of directing stem cells to acquire the proper identity, an essential step in the development of effective and durable cell replacement therapies. Specifically, we will talk about the process of directing cells into a ventral mesencephalic dopaminergic fate for treating Parkinson's disease. GuestsAgnete Kirkeby is an Associate Professor in the Department of Neuroscience at the University of Copenhagen, a Principal Investigator with the Novo Nordisk Foundation Center for Stem Cell Medicine renew, and a Principal Investigator at the Wallenberg Center for Molecular Medicine at Lund University. Professor Kirkeby led the preclinical development of a stem cell-based therapy for Parkinson's Disease which was approved for a first-in-human clinical trial in Sweden. Agnete also co-chairs the ISSCR 2024 Annual Meeting Program Committee, the group responsible for planning the upcoming meeting this July in Hamburg, Germany. Pedro Rifes received his PhD from the Universidade de Lisboa in Portugal and was a postdoctoral scholar in the Kirkeby Laboratory. He served as an Adjunct Assistant Professor at the University of Copenhagen and is currently a Project Manager at Bioneer A/S, a Danish specialty Contract Research Organization.  Connect with him on LinkedIn.HostMartin Pera, Editor-in-Chief, Stem Cell Reports and The Jackson Laboratory@martinperaJAXSupporting ContentPaper link: Forced LMX1A expression induces dorsal neural lolfates and disrupts patterning of human embryonic stem cells into ventral midbrain dopaminergic neurons, Stem Cell Reports About Stem Cell ReportsStem Cell Reports is the open access, peer-reviewed journal of the International Society for Stem Cell Research communicating basic discoveries in stem cell research, in addition to translational and clinical studies. Stem Cell Reports  focuses on original research with conceptual or practical advances that are of broad interest to stem cell biologists and clinicians. X: @StemCellReportsAbout ISSCRWith nearly 5,000 members from 75+ countries, the International Society for Stem Cell Research (@ISSCR) is the preeminent global, cross-disciplinary, science-based organization dedicated to stem cell research and its translation to the clinic. The ISSCR mission is to promote excellence in stem cell science and applications to human health.ISSCR StaffKeith Alm, Chief Executive OfficerYvonne Fisher, Managing Editor, Stem Cell ReportsKym Kilbourne, Director of Media and Strategic CommunicationsJack Mosher, Scientific AdvisorVoice WorkBen Snitkoff  

Send us a Text Message.Jill Pellegrino is CEO of AutoCruitment ( https://www.autocruitment.com/ ), a company with a focus on identifying, targeting, and qualifying patients for clinical trials with direct-to-patient recruitment, technology, and engagement services and which has to date been involved in randomizing over 12,000 patients into clinical trials across more than 120 conditions for clients including Pharmaceutical, Biotech, and Contract Research Organizations. Jill has over 15 years of leadership experience in patient recruitment, real world evidence and clinical research site operations and is passionate about growing businesses that rely on innovative, data driven methods to reach patients to provide them with opportunities to participate in research opportunities. Most recently Jill was at CVS Health where she was responsible for establishing and growing the Real World Evidence and Patient Recruitment businesses and her businesses were successful in placing 35,000 patients into research opportunities in both clinical trials and research settings, drastically increasing diversity participation in research studies. Prior to CVS Health, Jill was General Manager of Accelerated Enrollment Solutions, which was comprised of 2,000 employees across 11 countries and encompassed a patient recruitment offering and clinical research site network of 160 sites. Jill received her Bachelors degree from LaSalle University in Mathematics and Computer Science. Support the Show.

For n-Lorem's Chief Operating Officer, Sarah Glass, the mission of n-Lorem is personal. Her son Ethan was diagnosed with a nano-rare mutation. A geneticist by training, she joined n-Lorem to oversee and direct the organization's efforts to provide hope and potential help to those who need it most. It's more than just a job for her; she's powered by her son and the entire nano-rare community. 1:20 Sarah's background, early life, and scientific interests 7:20 Thinking about the patient experience while at a Contract Research Organization 8:43 Rare disease trails are relatively new 10:54 Sarah's son, Ethan, is a nano-rare patient 16:15 How long it took for Ethan to receive a diagnosis 21:35 Ethan's diagnosis and symptoms25:55 How Sarah heard about n-Lorem29:30 How does one come to terms with caring for a nano-rare child; How do parents continue looking for opportunities of hope when they may feel hopeless32:58 What Sarah has learned while at n-Lorem36:48 The biggest surprises Sarah has encountered during her journey at n-Lorem

If you are on the hunt for your perfect nonclinical role, you've probably heard a lot of different job titles - but what do these positions really entail? Today we are opening the ‘black box' of pharma once again to shed light on Medial Monitors, with special guest and former client Dr. Jason Steinberg. Dr. Steinberg highlights the responsibilities of a medical monitor at a large Contract Research Organization, and how he found both job satisfaction and a work-life balance in this field. You can find the show notes for this episode and more information by clicking here: www.doctorscrossing.com/episode158    In this episode we're talking about: Dispelling the mystery around this nonclinical profession How burnout and repetition led Dr. Steinberg to the white coat crossroads The day-to-day duties of a medical monitor How to process adverse event reports What really goes on in a bid defense meeting Who would be a great fit for this role Important details such as compensation and qualifications   Links for this episode: What Exactly Does A Medical Monitor Do - Blog with Dr. Kelly Curtis Pharma Insider's Guide - Get an overview of the different areas for physicians in pharma as well as tips to start building your platform to make a transition.  

Diversity Initiatives Actually Being Implemented At The Contract Research Organization Level LICR: http://www.latinosinclinicalresearch.com Daniel's LinkedIn: https://www.linkedin.com/in/daniel-a-perez-ccrp-he-him-04695232/

Today I was able to speak with Monica Schmiede, co-founder of Athelo Health, the first biometric-anchored virtual coach for women with breast and gynecologic cancers. I connected with Monica thanks to a mutual friend. As soon as I did a little digging on her background (it's impressive to say the least) and what Athelo Health is all about, I needed to have her on the show. The digital health field is one that I am just starting to understand. It's not only Fitbits and checking steps on an Apple Watch. I know a bit about how biometric information can support the overall health of an individual, and as Monica points out, make it easier to communicate more efficiently with our physicians. Let me tell you, in the hour I had with Monica, I realized I have only scratched the surface of what's possible. Sometimes it takes someone who has been in all of the different rooms and see other perspectives, those of the doctor, the patients who don't have equitable access, the clinical trials and more, to really connect the dots and unlock a potential I would have never seen coming.Here's what we talk about:  The 3 pillars Athelo health is built upon, starting with how harnessing biometric data provides awareness and a starting point for those patients who are diagnosed, or starting their remission journeyWhat brought her and her co-founder togetherThe origin story of Athelo Health and how it has grown She sneaks in so many little nuggets and facts or stats that will knock you off your feet, to her it's everyday info, to me it was wow moment after wow momentThe list goes on…A bit more about Monica:Monica Schmiede the the co-founder and Head of Commercial Strategy at Athelo Health, a health technology company focused on empowering women with breast and gynecologic cancers. Previously, she led business development and strategic partnerships for Clinipace, a mid-sized Contract Research Organization specializing in oncology clinical research where she grew revenue by 30%. She started her career in healthcare at Informa Pharma Intelligence where she built market intelligence portfolios for both innovative biotechnology companies and global pharmaceutical companies. She holds an MBA from the London School of Economics and currently resides in Marin, California. In addition, she enjoys spending her free time in nature and is an avid freediver.Thank you Monica for coming on and sharing your knowledge today! I'm so grateful to have had time to pick your brain and I cannot wait to see how Athelo Health continue to grow and evolve. LINKS:Athelo Health- https://athelohealth.com/Outside the Box Cancer Therapies: Alternative Therapies That Treat and Prevent Cancer by Dr. Mark Stengler & Dr. Paul Anderson- https://amzn.to/3MO3CnTIn the FLO: Unlock Your Hormonal Advantage and Revolutionize Your Life- https://amzn.to/3MOshIYThank you for spending time with me! Don't forget to rate and review wherever you listen to podcasts.Thanks for your support. I'll be back soon with some more inspiring conversations with inspiring humans...-BrittCleaning up your routine? Check out my baby: TheStyleShaker.comYou can also follow me for more on Instagram @brittwitkin

More than a decade ago, Bruno Boulanger made a big bet on applying Bayesian statistics in clinical trials. At the time, very few in the industry thought the method, which applies probabilities to statistical problems, had a place in clinical development. Boulanger saw an opportunity, founding a company that quickly grew and was acquired by CRO PharmaLex in 2018, where he now serves as global head of statistics and data science.In this episode, Boulanger explains how Bayesian statistics uses probability and prediction to solve challenges in the increasingly complex world of clinical research and clinical trial design. Bayesian statistics allows researchers to expand decision making for clinical trials beyond its participants, which is imperative for trials targeting rare diseases. Looking forward, Boulanger is optimistic about the expansion of therapeutic innovation combined with digitalization and data science to meet the unmet needs of patients. All presentations represent the opinions of the presenter and do not represent the position or the opinion of SAS.

The internet has given content creators of all kinds a way to monetize their talents. Writers have Medium. Teachers and vloggers have YouTube.  But scientists don't have a platform to earn money for their research.  That's why Dr. Jocelynn Pearl calls scientists the ‘unappreciated creator class.' And that's why she's working to further the DeSci movement, leveraging Web3 technology to enable breakthrough research through better incentives. A molecular and cellular biologist by training, Jocelynn serves as cofounder of LabDAO, a design marketplace for life science research, and host of The UltraRare Podcast, a show about the builders behind the decentralized science movement. On this episode of Boost VC, Jocelynn joins us to explain how DeSci solves for speed of translation and communicates science better than existing systems, exploring how the movement might specifically facilitate breakthroughs around rare disease. Jocelynn discusses how academia owns the best scientific minds without rewarding them appropriately and describes how DAOs offer alternatives to classic academic publishing and drug development. Listen in as Jocelynn makes the case that scientists are the unappreciated creator class and learn how access to the right advisors and capital can accelerate the decentralized science movement. Topics Covered How Jocelynn defines scienceProcess of exploring unanswered questionsConversation among people trained to be critical How Jocelynn defines decentralized scienceWay of democratizing resourcesCommunicate science better than existing systems What inspired Jocelynn's interest in DeSciCentralization of research inhibits progressSolve for speed of translation, cost reduction How DeSci might facilitate breakthroughs in rare diseaseExplore drug development through DAOsCommunication of collective knowledge Leveraging DeSci to incentivize scientific researchChange academic publishing through tokenizationAllow patient group to co-own drug development Why Jocelynn sees scientists as the unappreciated creator classWriters have Medium, vloggers have YouTubeNo platform for scientists to monetize content What needs to change for scientists to be appreciated creatorsActivists like Seemay Chou who encourage sharingAlternative model to academic publishing How academia owns the best minds (without rewarding them)Earn $30K/year working full-time in PhD programDoes form you as scientist and provides network How CROs address the lab space shortageStands for contract research organizationFarm out research can't perform in-house The challenges of establishing decentralized scienceTraditional academia and publishing will fight backMuch work required to override existing system What's stopping the DeSci space from accelerating fasterStruggles to bring in advising and capitalWorking on projects outside day jobs Jocelynn's definition of success Lasting change in scientific ecosystemPivot how progress happens  Connect with Jocelynn Pearl Jocelynn's Website https://www.jocelynnpearl.com/LabDAO https://www.labdao.xyz/LabDAO on Twitter https://twitter.com/lab_daoLabDAO on GitHub https://github.com/labdao  LabDAO on Discord https://discord.com/invite/labdaoUltraRare Podcast https://rss.com/podcasts/ultrarare/ Resources A Guide to Decentralized Biotech https://future.com/a-guide-to-decentralized-biotech/The DeSci Wiki https://www.jocelynnpearl.com/Molecule Protocol https://www.molecule.to/Ben Hills https://twitter.com/0xboodleVibe Bio https://www.vibebio.com/Experiment.com https://experiment.com/Arcadia Science https://www.arcadia.science/Invisible College https://www.invisiblecollege.xyz/Charles River Laboratories https://www.criver.com/Cameron & Tyler Winklevoss on Boost VC EP102 https://podbay.fm/p/the-boost-vc-podcast/e/1606903200Manhattan Project https://www.history.com/topics/world-war-ii/the-manhattan-projectThiel Fellowship http://www.thielfellowship.org/ Connect with Boost VC Boost VC Website https://www.boost.vc/Boost VC on Facebook https://www.facebook.com/boostvc/Boost VC on Twitter https://twitter.com/BoostVCBoost VC on Instagram https://www.instagram.com/boost_vc/ 

In the first episode of our new podcast series, 'Stories From The Marketplace', I sit down with Catherine Lund. Catherine is the Director of OnQ Research, a Contract Research Organization. Join in as we hear more about Catherine's business journey in an emerging market. You can also find out more about her company here: https://www.onqsa.co.za/ Connect with Brett Johnson on social media: Facebook Instagram Twitter LinkedIn Visit brettjohnson.biz for articles, devotionals, and more.

Biotech scientist, Mike Donio was fired for his refusal to comply with injection mandates. Join him and myself for a deep dive into why he's now speaking out against the industry, how trusting the science is exactly what we shouldn't do, and what the scientific method really is. He's going to show us the unknown mechanism for most approved drugs, and improper models and artifacts of preparation, insider knowledge about the reproducability crises, cancer, viruses, and fraudulent tests. Mike's aim is to encourage more scientists to speak out and for the people to become their own experts. Jump on the livestream Wednesday March 2, 1:00 PM CST or watch the recording below after that time. Read More About Him: Mike Donio holds a bachelor's degree in Biochemistry and Molecular Biology with a Minor in Chemistry from the University of Massachusetts and a master's degree in Biotechnology with a concentration in Biotechnology Enterprise from JohnsHopkins. He is an accomplished scientist with 20 years of experience, including 15 years in the biotech and pharmaceutical industry. This experience spans the spectrum of drug discovery ranging from target identification through pre-clinical and IND-enabling studies. His first job as a scientist was in the lab of a top infectious disease doctor doing HIV research. Following that, he went into the pharma industry working several years at Schering-Plough which was subsequently acquired by Merck. Next, he decided to mix things up and worked for a few years at Eurofins, a Contract Research Organization. Finally, he spent the last 6 years at a biotech company in the Immuno-Oncology space, where he was most recently a Senior Scientist, developing antibodies to treat cancer. Despite this extensive experience and accomplishments over the last 20 years, Mike was let go from his most recent role at the biotech company for not consenting to take the Covid vaccine due to his deeply held religious beliefs. Follow Mike here: Channel: https://t.me/scientistsforhealthfreedom Chat: https://t.me/S4HFchat Blog: https://stillinthestorm.substack.com --- Send in a voice message: https://anchor.fm/beth-martens/message

On this Alfacast Biotech scientist, Mike Donio tells us why he did not comply with the Cootie Mandate and that "the Science" is not to be trusted. Biotech scientist, Mike Donio, has quite a story to tell! With advanced degrees in Biochemistry & Molecular Biology from esteemed universities including a concentration in Biotechnology Enterprise from Johns Hopkins he'll share the inside scoop on the so-called Scientific Method. During Mike's two decades in the biotech and pharmaceutical industry he witnessed first-hand how trusting the science is exactly what we shouldn't do, and what the Scientific Method really is. He's going to show us the unknown mechanism for most approved drugs, and improper models and artifacts of preparation, insider knowledge about the reproducibility crises, cancer, viruses, and fraudulent tests. This experience spans the spectrum of drug discovery ranging from target identification through pre-clinical and IND-enabling studies. His first job as a scientist was in the lab of a top infectious disease doctor doing HIV research. Following that, he went into the pharma industry working several years at Schering-Plough which was subsequently acquired by Merck. Next, he decided to mix things up and worked for a few years at Eurofins, a Contract Research Organization. Finally, he spent the last 6 years at a biotech company in the Immuno-Oncology space, where he was most recently a Senior Scientist, developing antibodies to treat cancer.  Despite this extensive experience and accomplishments over the last 20 years, Mike was let go from his most recent role at the biotech company for not complying with the Cootie mandate due to his deeply held religious beliefs. Mike's aim is to encourage more scientists to speak out and for the people to become their own experts. We couldn't agree more, and Mike's courage to speak the truth during these times of universal deceit bespeaks the revolution in Consciousness now underway! Show Links: https://t.me/scientistsforhealthfreedom Join Our Telegram: https://t.me/aflavedic    

Episode 39: Mike Donio - Scientist Questions The Science Mike Donio holds a bachelor's degree in Biochemistry and Molecular Biology with a Minor in Chemistry from the University of Massachusetts and a master's degree in Biotechnology with a concentration in Biotechnology Enterprise from Johns Hopkins.  He is an accomplished scientist with 20 years of experience, including 15 years in the biotech and pharmaceutical industry.  This experience spans the spectrum of drug discovery ranging from target identification through pre-clinical and IND-enabling studies.  His first job as a scientist was in the lab of a top infectious disease doctor doing HIV research.  Following that, he went into the pharma industry working several years at Schering-Plough which was subsequently acquired by Merck.  Next, he decided to mix things up and worked for a few years at Eurofins, a Contract Research Organization.  Finally, he spent the last 6 years at a biotech company in the Immuno-Oncology space, where he was most recently a Senior Scientist, developing antibodies to treat cancer.  Despite this extensive experience and accomplishments over the last 20 years, Mike was let go from his most recent role at the biotech company for not consenting to take the Covid vaccine due to his deeply held religious beliefs. Mike joins me to talk about his journey of realising that something was amiss in the world of science. In this podcast we discuss the failings of the scientific method, scientism and scientific dogma, cancer research, drug research, HIV research and much much more. If you are a scientist and like Mike, you are also questioning things, head on over to his telegram channel "Scientists For Health Freedom" which has over 200 scientists from around the world speaking out about the "science" https://t.me/S4HFchat Disclaimer: This podcast is for general information purposes only. It does not constitute as health advice and does not take the place of consulting with your primary health care practitioner. The views and opinions expressed in this podcast are those of the guest speaker and do not necessarily reflect those of Humanley, the presenter or any other entities or third parties associated with Humanley or the presenter. The right to freedom of opinion is the right to hold opinions without interference, and cannot be subject to any exception or restriction. We encourage the audience to use their critical judgement and use due diligence when interpreting the information and topics discussed in this podcast.

Mrs. Mutiah T Macaulay is the Founding Partner/CEO of a Contract Research Organization on bridging the gap of Clinical Research in Africa. She shares her amazing journey of how she went from a regional CRA to an international CRA and CEO. She also discusses her participation in various Research programs at the National Institute of Health, National Cancer Institute, Clinical Research Organizations, Public Health sectors, Pharmaceutical companies and various Academia institutes provided her with immeasurable experience. If you are wondering how you can branch out from the traditional CRA role, this is definitely another episode you don't want to miss.

Jennifer Byrne, CEO of contract research organization Javara Research, has a lifelong passion for serving patient populations through clinical research. On this episode, Jennifer shares with Greg the concept of learning health systems that improve health care through research. Javara brings a lot of the traditional advantages that a CRO brings to pharma to health care systems through an integrated research organization approach. The organization's strategic vision and partnerships are centered around bringing clinical research opportunities to health care systems to meet unmet patient needs while simultaneously partnering with pharma to address the data and scientific needs to clinical trials. Jennifer explains how analytics and AI are used to deep dive into electronic health records and other health data sources to identify potential clinical trial participants and connect the right patient with the right trial and the right time. Greg asked Jennifer about the role of bias in clinical research, and she shares her experience around bias that patients and physicians aren't as interested in participating in clinical research as they actually are. Technology can assist in physician and patient outreach and engagement, so that patients can come to clinical research with their trusted physician and keep their clinical trial participation in sync with their overall health care journey. They also discuss opportunities to use technology to deliver optimal and more patient-centric clinical trial participation. 

This discussion was first presented in June of 2019. It was in response to one of the most common questions brought up in the Physician Nonclinical Career Hunters Facebook Group. Your MD or DO degree is valuable. It enables you to compete for jobs with PhDs and PharmDs. Remember, too, that these jobs are open to residency-trained physicians, often at slightly higher salary levels to start. 1. Medical Writing For physicians looking for flexibility and work they can do from home, medical writing may be the answer. With a vast range of options, from blog articles to technical writing, discouraged doctors are sure to find something that fits their needs. 2. Clinical Documentation Improvement Medicare regulations have caused an explosion of companies focused on Clinical Documentation Improvement (CDI). As a CDI professional, you will be trained in the intricacies of translating chart notes and discharge summaries to appropriate billing codes. This work is extremely important to hospitals because it determines whether appropriate payments are collected and how quality measures are reported. 3. Medical Communications Generally, you'll be working in marketing agencies that deal with pharma and device companies. It's a great role if you enjoy working in a conventional office with a regular schedule. Teamwork and communication skills are important. There are ad agencies that hire medical directors in most major metropolitan areas of the U.S. 4. Consulting Consulting can be an excellent career choice for physicians lacking postgraduate training. Firms sometimes prefer doctors without experience so they can train them to their way of doing things, without the need to break old habits. Depending on the firm and your location, it may require significant amounts of travel. It can be very lucrative, though, with opportunities for advancement. 5. Medical Monitor Doctors with experience working in research or on pharmacy committees are suited to a career as a  medical monitor. Medical monitors support research studies and ensure that they are medically sound. They track adverse drug reactions. And they serve as liaisons between principal investigators and the coordinating Contract Research Organization or pharmaceutical company. 6. Medical Science Liaison An MSL is a good entry-level job in the pharmaceutical space. Ideal candidates must be familiar with the regulatory landscape. This career involves regular travel and meeting new people. The course Introduction to 6 Nonclinical Careers Any Physician Can Pursue will walk you through the process of finding your first MSL position. Summary There are many jobs in the healthcare industry available to physicians without residency training. Since the original episode aired, additional jobs have been presented here on the podcast. In Pharma, there are jobs beyond MSL and medical monitor positions.  In Episode 209, Dr. Marsha Caton described the tactics for landing clinical scientist, clinical research associate, or technical medical writer jobs. And there will be more on that subject in Episode 214 with Dr. Laura McKain. To access the show notes and all of the links for this episode, go to nonclinicalphysicians.com/no-resideny-is-no-problem If you'd like to join my NEW Nonclinical Mastermind Group, you can learn about it at nonclinicalphysicians.com/mastermind. Get an updated edition of the FREE GUIDE to 10 Nonclinical Careers at nonclinicalphysicians.com/freeguide. Get a list of 70 nontraditional jobs at nonclinicalphysicians.com/70jobs. Check out a FREE WEBINAR called Best Options for an Interesting and Secure Nonclinical Job at nonclinicalphysicians.com/freewebinar1

If you're considering a career transition into pharma but don't think you have the desired background, this podcast is for you. There are a variety of ways you can build your resume if you plan in advance. Our guest, oncologist Dr. Kelly Curtis, works as a Senior Medical Director where he oversees clinical trials at a Contract Research Organization. Dr. Curtis shares a number of actionable steps you can take while still in practice to increase your chances of being hired into pharma. You can find the show notes for this episode and more information by clicking here: www.doctorscrossing.com/27

Today, we talk with Jessie and Bobby Louque, of Louque Agricultural Enterprises.  Testing the interactions of pesticides and honey bees is what this company does on a daily basis. They have combined their passion for bees with their passion for science. They are what is called a Contract Research Organization, or CRO. Companies hire them to do the specialty research required with honey bees to provide the EPA with the measures and data needed to make decisions on the introduction or expansion of a pesticide or honey bee food label. When a new product is going to be introduced or its use expanded, the EPA requires a lot of data on interactions with humans, mammals, birds and pollinators. The companies start with lab studies then ultimately to very controlled field studies. They want various rates, times and techniques of application studied on different crops measured. They want to know if exposure kills on contact in the field, or is it brought back to the hive and kills bees there. Then they want to know if the colony is able to continue to reproduce and if will it survive the winter. Thousands of Colony Collection Assessments are made, where every frame in every hive in the study, and there are often 150 or more, is measured for bees, open and sealed brood, nectar and honey percentages. This is done at least nine times for a study. They hire CROs to perform this independent testing. For field testing with honey bees, they call Jessie and Bobby. And at the end of a test, what happens to all the equipment, from hives to tools? Listen today to find out! The answer may surprise you! Links and websites mentioned in this podcast: Jessie's Instagram Feed - https://www.instagram.com/jessie.l.louque/ Honey Bee Obscura Podcast - https://www.honeybeeobscura.com Bee Informed Partnership - https://beeinformed.org Kim's Book Review, "Commercial Beekeeping - A Field Guide" - https://www.bipinc.org/store/p7/Commercial_Beekeeping%3A_A_Field_Guide.html ______________ Thanks to Strong Microbials for their support of Beekeeping Today Podcast. Find out more about heir line of probiotics in our Season 3, Episode 12 episode and from their website: https://www.strongmicrobials.com This episode is brought to you by Global Patties! Global Patties is a family business that manufactures protein supplement patties for honey bees. Feeding your hives protein supplement patties will help ensure that they produce strong and health colonies by increasing brood production and overall honey flow. Global offers a variety of standard patties, as well as custom patties to meet your specific needs. Visit them today at http://globalpatties.com and let them know you appreciate them sponsoring this episode!  We want to also thank 2 Million Blossoms as a sponsor of the podcast. 2 Million Blossoms is a quarterly magazine destined for your coffee table. Each page of the magazine is dedicated to the stories and photos of all pollinators and written by leading researchers, photographers and our very own, Kim Flottum. _______________ We hope you enjoy this podcast and welcome your questions and comments: questions@beekeepingtodaypodcast.com Thanks to Bee Culture, the Magazine of American Beekeeping, for their support of The Beekeeping Today Podcast. Available in print and digital at www.beeculture.com Thank you for listening!  Podcast music: Young Presidents, "Be Strong", Musicalman, "Epilogue" Beekeeping Today Podcast is an audio production of Growing Planet Media, LLC

Adam Field, a senior scientist at Sygnature Discovery shares his experience working in CRO. Check out the full podcast episode! --- This episode is sponsored by · Anchor: The easiest way to make a podcast. https://anchor.fm/app

There is no denying being a surgeon is stressful. Long days in the OR, operating in the middle of the night, complications, too much time doing administrative duties… It's no wonder surgeons are looking for nonclinical options. Dr. Tracy Pitt, a bariatric surgeon, shares his story of leaving medicine for a job in drug safety with a Contract Research Organization. Find out how he did it and why he's not looking back.    You can find the show notes for this episode and more information by clicking here: www.doctorscrossing.com/13

Would you volunteer to be a human guinea pig in a clinical trial for Covid19 vaccine? Would you be more likely to volunteer, if you were being paid? And if did take part, what safeguards if any would you want in place? The history and ethics of Human Clinical trials.

Would you volunteer to be a human guinea pig in a clinical trial for Covid19 vaccine? Would you be more likely to volunteer, if you were being paid? And if did take part, what safeguards if any would you want in place? The history and ethics of Human Clinical trials.

This week, I bring you my conversation with a former academic pediatrician who transitioned to a career as medical director with a contract research organization, or CRO. Dr. Michelle Bailey received her medical degree from State University of New York (SUNY) Downstate Health Sciences University and completed her pediatrics residency at Duke University Medical Center. She trained in the Integrative Medicine Fellowship through the University of Arizona, and served on the faculty of Duke University School of Medicine for many years. She is also a life and career coach, helping other physicians find fulfillment and balance in their personal and professional lives. You may notice during the interview that she has the heart of a coach and mentor. Michelle helped me get a better understanding of the options for physicians in the pharmaceutical industry. I now understand the difference between the medical director working in medical affairs or safety and pharmacovigilance, the medical monitor, the medical science liaison, and the clinical research associate. If you’d like to access a transcript of the episode and links to the resources mentioned during our conversation, go to vitalpe.net/episode124.

KGK Science is a contract research organization that specializes in human clinical trials for the nutraceutical, dietary supplement and functional food industry and is KGK Science is an industry-leading Contract Research Organization accomplished in the design and execution of Phase I-IV clinical trials within the dietary supplement, functional food, and natural product industries. With locations in both Canada and the United States, we are recognized internationally for their ethical and specialized study of natural health products. Established in 1997, KGK's dedicated and experienced staff consists of board-certified physician-investigators and certified clinical research coordinators.

Kiran Krishnan Research Microbiologist & Chief Science Officer at Microbiome Labs https://microbiomelabs.com Kiran has been involved in the dietary supplement and nutrition market for the past 15 years. He comes from a strict research background having spent several years with hands-on R&D in the fields of molecular medicine and microbiology at the University of Iowa. He left University research to take a position as the U.S. Business Development and Sales Manager for Amano Enzyme, USA. Amano is one of the world’s largest suppliers of therapeutic enzymes used in the dietary supplement and pharmaceutical industries in North America. At Amano, he conceptualized and successfully launched several dietary supplement ingredients in the North and South American markets. In addition to his experience at Amano, Kiran has designed and conducted over 10 clinical trials as a partner in a Contract Research Organization called Live Smart, Inc. Over the past 10 years Kiran has focused his knowledge and experience to developing unique and effective nutritional products for other well-known brands in the dietary supplement market. Kiran has had several market successes in the dietary supplement and nutrition markets. He brings his extensive technical knowledge, his clinical research experience and his passion for creating effective, natural products to Microbiome Labs. As a microbiologist, he has a deep understanding of microbial science and has spent the last 6 years studying the strains used in Microbiome Labs.

In this episode, Dr. Christian Urrea provides insight into his nonclinical career. He realized in medical school that he did not want to pursue a traditional clinical career. So he developed a plan to help patients in another way. Prior to medical school, he had worked as a clinical research assistant and used that experience, along with his M.D. to land a job in the quality improvement department of a community hospital and physician hospital organization. In that role, he worked with physicians to improve compliance with payer quality programs and broadly speaking helped achieve the Triple Aim of improving quality and patient care while reducing costs. That job enabled Christian to gain experience working with medical peers and coordinating teams to achieve desired organizational goals. He next set his sights on a career as an MSL. In the course of that job search, he was able identify a mentor who help Christian accelerate his job search. And he found that work as a medical monitor for a Contract Research Organization would better align with his skills and interests. During our interview, Christian shares what he learned during his career journey. He specifically addresses the following topics: The importance of identifying mentors; How LinkedIn can facilitate your career search; How great jobs as an MSL or a medical monitor are available to non-licensed physicians with the porper planning and approach;  What he likes about working for a CRO; Some of the challenges a medical monitor faces. There are links to resources mentioned in this episode and a transcript at vitalpe.net/medicalmonitor

“Technology makes our lives easier, but it doesn’t replace people” - Melissa “Liss” Easy The dynamic, engaging Melissa “Liss” Easy is the Founder of clinical operations technology provider DrugDev, which is now part of IQVIA. Early in her career Liss was consulting to a Contract Research Organization and became frustrated by inefficiencies in matching investigators to pharma protocols. She started DrugDev to bring sponsors and investigators together by focusing on the needs of the doctors, giving them better technologies and service and more open communication.The DrugDev network Liss began now hosts over 85,000 active investigators in 120 countries in addition to profile and experience information for 450,000+ investigators from 85 pharma and biotech companies. And, DrugDev has expanded to offer a suite of clinical operations solutions used on nearly 2,000 clinical trials.Liss’s honors include being named one of the PharmaVOICE 100 most influential people in life sciences; winning the Partnerships in Clinical Trials Woman of the Year award; and, being named to the a Philadelphia Business Journal Healthcare Innovator.Liss is an extraordinary example of how radical change is creating a new phase in clinical research. I hope you’ll enjoy hearing this extraordinary woman's perspective on how technology can fundamentally change clinical trials and global healthcare for the better.About This Podcast EpisodeListen to it on iTunes.Stream by clicking here.Download as an MP3 by right-clicking here and choosing “save as.” This episode is brought to you by CBI Events CBI has put together an Global Risk Based Monitoring event for clinical research professionals such as yourself. CBIs Global Risk-Based Monitoring event is back for its third year to bring together thought leaders from around the world to benchmark, share best practices, evaluate technologies, overcome operational hurdles and make the most out of RBM. Attend this year’s event to gain best practices in protocol design, receive hands-on demonstrations of new technologies that you cannot learn in an RBM webinar, benchmark face-to-face with peers, develop new strategies in algorithm design and prepare for the future of RBM. Register today and get your $500 off your registration using the promo code CTP500. This is an exclusive offer is only available to the Clinical Trial Podcast listeners. Selected Links from the EpisodeDrugDev Society of Clinical Research Sites Why Isn't Your CRO Using E-Consent? Exl Events Investigator Database Bank connecting investigators with sponsors and CROs LastPass, an amazing password management tool SCRS Summit Books Lean In: Women, Work, and the Will to Lead by Sheryl Sandberg Show Notes: Making new pharmaceutical products available to patients who need them sooner [02:20] Making the leap from advertising and marketing  [03:38] Disney to Drugs [05:10] Working on large deals at a CRO and pulling people together from different departments [06:23] Creating like a LinkedIn for investigators and sponsor companies  [07:24] Moving away from contacting physicians via faxes to contacting them via email [08:26] Is there legal or regulatory reason as to why you can't do this in clinical research? [08:50] Reaching out to people your network, asking people what they want and questioning assumptions  [10:19] Electronic patient consent [11:02] Fostering site and industry collaborations via the Investigator Database Bank [13:52] How to make sites lives easier? [15:09] Process for developing strategic partnerships with other organizations [16:22] Everyone wants experienced investigators, but if no one gives them that first chance [18:09] Advice for start-up founders [20:28] Choosing and attending conference [21:47] What are we doing in the 21st century that we must stop doing right now and get ready to change? [22:52] User experience, doing everything just once, and batching tasks [29:42] Once the site is activated, don’t expect them to magically come up with patients [30:34] Ensuring you have a steady study pipeline as a clinical trial site [32:10] Is joining a site network worth it? [35:48] Getting started with new software technologies and importance of staff training [40:04] If you hire someone to do some work, you have to trust them [42:20] Hiring people [43:57] People underestimate how hard it is to manage people remotely [46:17] Building relationships, genuine relationships and being interested in people [47:43] You should listen to people, whether they be more senior or junior than you [49:46] Being a female, there are some additional challenges that you can have in the workplace [54:00] Subscribing to newsletters and attending conferences [55:22] Advice to her younger self [57:55] QUESTION: What was your favorite lesson from this episode? Leave me a comment below and thanks for listening.

n this video we discuss why CRO turnover is so high and why people leave their jobs. CRO stands for Contract Research Organization or Clinical Research Organization which it is sometimes called. Often times the job market gets red hot and the turnover becomes incredibly high and it becomes very hard to keep employees for the longterm. This video we talk some of those reasons as to why CRO turnover is so high, in another video we discuss ways to mitigate that turnover. Follow us on youtube: https://www.youtube.com/channel/UCe_8NUyFNS-dBLWq5Mi0eJg --- This episode is sponsored by · Anchor: The easiest way to make a podcast. https://anchor.fm/app --- Send in a voice message: https://anchor.fm/clinical-research-podcast/message Support this podcast: https://anchor.fm/clinical-research-podcast/support

Lots of exciting content in this episode of the OPP. We sit down with Natural Stacks co-founder Roy Krebs. Tons of exciting announcements and chances to win cool stuff! We're really excited to give you a chance to win a Concept 2 Rower! We're always looking to hook you guys up stuff you'll love. Enter here. CILTEP Studies coming soon -2 large scale, double-bling placebo controls with two groups healthy adults, and healthy elderly. Of course, these are top notch University studies instead of a Contract Research Organization (which many other supplement companies use) which leave room for manipulation. NEW PRODUCTS FOR 2018 -Ciltep to-go pack! Take it with you when you travel. No-brainer. -This March we're releasing a drink! Won't say which product though (wink) - Targeted probiotic products for memory, focus and sleep. Roy is developing a probiotic supplement which will be for specific optimization. Studies are showing that specific strains help specific areas and Roy is working to optimize probiotics.  - Better Blue Blocker Glasses - along with an eye health supplement sold as a stack NEW CONTENT FOR 2018 -We'll be looking at developing some online courses in collaboration with the NS Board of Directors - who are experts in nutrition, brain training and the body. -OPP as a whole, will continue to evolve and focus on useable, accessible content that everyone can use.  -We may be reaching out to you to hear your story and potentially have you on the podcast to share your journey with everyone.  Roy is a master innovator as you probably already know, so it should come as no surprise that he's working on a dozen projects all at once. But the best part about it - everything Roy develops is done with transparency, high ethics and accountability to the absolute best possible ingredients. As Roy mentioned, every batch of every product is tested and results posted online for you to see.  As always, we want to hear from you. We want your feedback, reviews, thoughts and concerns. If you have a cool show idea - we want to hear it. If you have a cool story to tell - let us know. If you want to be an affiliate, email ben@naturalstacks.com Stay tuned folks, there's a lot more where this came from! Sean   Follow Sean McCormick Instagram: http://bit.ly/OPPMac Twitter: http://bit.ly/OPPMacTwitter   Follow Natural Stacks Twitter: http://bit.ly/NsTwitter Instagram: http://bit.ly/NsInstagram Facebook: http://bit.ly/NsFacebook   SHOP NATURAL STACKS Shop: http://bit.ly/OPPShop